Sanofi Expands Vaccine Portfolio with $1.6 Billion Acquisition of UK's Vicebio

Sanofi is set to acquire UK vaccine firm Vicebio for up to $1.6 billion, aiming to expand its respiratory virus vaccine pipeline with Vicebio's 'Molecular Clamp' technology and a p...